ORG Wealth Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.23K Buy
+210
New +$5.64K ﹤0.01% 1026

Other funds holding ACAD

ORG Wealth Partners's ACAD Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 210 shares worth $4.23K. The stake represents ﹤0.01% of the portfolio and ranks #1026 among its holdings.

351 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • ORG Wealth Partners held 210 shares of Acadia Pharmaceuticals worth $4.23K as of Q3 2026.
  • Acadia Pharmaceuticals was a new ORG Wealth Partners position in Q3 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #1026 holding.
  • 351 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.